Skip to main content
Clinical and Translational Medicine

Table 4 Relationship between CXCL9-11 polymorphisms (CXCL9 rs10336, CXCL10 rs3921, and CXCL11 rs4619915) and liver fibrosis in HCV-infected patients

From: CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study

 

Unadjusted

Adjusted

Exp(B) (95% CI)

pa

Exp(B) (95% CI)

pb

rs10336 AG

 LSM (kPa)

0.82 (0.73; 0.92)

0.001

0.85 (0.76; 0.95)

0.005

  F ≥ 2 (≥7.1)

0.55 (0.37; 0.83)

0.004

0.59 (0.38; 0.91)

0.016

  F ≥ 3 (≥9.5)

0.48 (0.31; 0.74)

0.001

0.54 (0.34; 0.86)

0.010

  F4 (≥12.5)

0.52 (0.31; 0.89)

0.016

0.56 (0.32; 0.98)

0.043

rs3921 CG

 LSM (kPa)

0.82 (0.73; 0.91)

<0.001

0.84 (0.76; 0.94)

0.003

  F ≥ 2 (≥7.1)

0.53 (0.35; 0.79)

0.002

0.56 (0.36; 0.86)

0.008

  F ≥ 3 (≥9.5)

0.49 (0.32; 0.76)

0.002

0.55 (0.34; 0.88)

0.013

  F4 (≥12.5)

0.54 (0.31; 0.91)

0.021

0.57 (0.33; 1.00)

0.051

rs4619915 AG

 LSM (kPa)

0.82 (0.73; 0.91)

<0.001

0.84 (0.76; 0.94)

0.003

  F ≥ 2 (≥7.1)

0.53 (0.35; 0.79)

0.002

0.56 (0.36; 0.86)

0.008

  F ≥ 3 (≥9.5)

0.49 (0.32; 0.76)

0.002

0.55 (0.34; 0.88)

0.013

  F4 (≥12.5)

0.54 (0.31; 0.91)

0.021

0.57 (0.33; 1.00)

0.051

  1. Exp(B) geometric mean ratio (GMR) continuous variable or odds ratio (OR) for categorical variables, 95%CI 95% of confidence interval, p value level of significance, LSM liver stiffness measure, kPa kilopascal, F ≥ 2 significant fibrosis, F ≥ 3 advance fibrosis, F4 cirrhosis, HCV-GT hepatitis C virus genotype, CXCL chemokine (C-X-C motif) ligand
  2. Statistical: a p values were calculated by univariate regression
  3. bp values were calculated by multivariate regression adjusted by the most important clinical and epidemiological characteristics (see “statistical analysis” section). Statistically significant differences are shown in italic
Back to article page